Isoptin

Dosaggio del prodotto: 120mg
Confezione (n.)Per compressePrezzoAcquista
30€1.13€33.94 (0%)🛒 Aggiungi al carrello
60€0.81€67.87 €48.36 (29%)🛒 Aggiungi al carrello
90€0.71€101.81 €63.63 (37%)🛒 Aggiungi al carrello
120€0.66€135.74 €78.90 (42%)🛒 Aggiungi al carrello
180€0.60€203.61 €107.75 (47%)🛒 Aggiungi al carrello
270€0.56€305.42 €151.86 (50%)🛒 Aggiungi al carrello
360
€0.55 Migliore per compresse
€407.23 €196.83 (52%)🛒 Aggiungi al carrello
Dosaggio del prodotto: 240mg
Confezione (n.)Per compressePrezzoAcquista
30€1.47€44.12 (0%)🛒 Aggiungi al carrello
60€1.10€88.23 €66.17 (25%)🛒 Aggiungi al carrello
90€0.99€132.35 €89.08 (33%)🛒 Aggiungi al carrello
120€0.92€176.46 €110.29 (37%)🛒 Aggiungi al carrello
180€0.86€264.70 €154.41 (42%)🛒 Aggiungi al carrello
270€0.82€397.05 €222.28 (44%)🛒 Aggiungi al carrello
360
€0.80 Migliore per compresse
€529.39 €286.76 (46%)🛒 Aggiungi al carrello
Dosaggio del prodotto: 40mg
Confezione (n.)Per compressePrezzoAcquista
60€0.61€36.48 (0%)🛒 Aggiungi al carrello
90€0.50€54.72 €44.96 (18%)🛒 Aggiungi al carrello
120€0.44€72.96 €52.60 (28%)🛒 Aggiungi al carrello
180€0.39€109.44 €69.57 (36%)🛒 Aggiungi al carrello
270€0.35€164.16 €93.32 (43%)🛒 Aggiungi al carrello
360
€0.33 Migliore per compresse
€218.88 €117.93 (46%)🛒 Aggiungi al carrello
Dosaggio del prodotto: 80 mg
Confezione (n.)Per compressePrezzoAcquista
60€0.49€29.69 (0%)🛒 Aggiungi al carrello
120€0.40€59.39 €47.51 (20%)🛒 Aggiungi al carrello
270€0.31€133.62 €83.14 (38%)🛒 Aggiungi al carrello
360
€0.28 Migliore per compresse
€178.16 €100.96 (43%)🛒 Aggiungi al carrello

Prodotti simili

Isoptin (Verapamil Hydrochloride): Comprehensive Clinical Monograph for the Management of Hypertension, Angina Pectoris, and Cardiac Arrhythmias

1. Introduction: What is Isoptin? Its Role in Modern Cardiology

Alright, let’s cut through the noise. Isoptin is the brand name for verapamil hydrochloride, and it belongs to the class IV calcium channel blockers—specifically, the phenylalkylamine subclass. This distinction matters because unlike dihydropyridines (amlodipine, nifedipine) which are primarily vasoselective, Isoptin has significant negative chronotropic and dromotropic effects on the sinoatrial and atrioventricular nodes. So it’s not just another blood pressure pill; it’s a rate-controlling agent with unique electrophysiological properties.

The drug was first synthesized in the early 1960s by Knoll AG (now part of Abbott), and it hit the US market in 1981. Since then, it’s become a workhorse for three main indications: essential hypertension, stable angina pectoris, and supraventricular tachyarrhythmias including atrial fibrillation with rapid ventricular response.

What sets Isoptin apart from beta-blockers? It doesn’t cause bronchospasm, which makes it a solid alternative in patients with asthma or COPD. But it’s not without its quirks—constipation is almost a hallmark, and the extended-release formulations can be tricky with dosing.

2. Key Components and Bioavailability of Isoptin

The active ingredient is verapamil hydrochloride, a racemic mixture of R- and S-enantiomers. The S-enantiomer is more potent for negative dromotropic effects (slowing AV conduction), while both contribute to vasodilation.

Formulations available:

  • Immediate-release tablets: 40 mg, 80 mg, 120 mg
  • Extended-release tablets (Isoptin SR): 120 mg, 180 mg, 240 mg
  • Extended-release capsules (Isoptin ER): 120 mg, 180 mg, 240 mg, 360 mg
  • Intravenous solution: 2.5 mg/mL, 5 mg/mL

Bioavailability quirks:

Here’s where it gets interesting. Oral bioavailability is only about 20-35% due to extensive first-pass hepatic metabolism via CYP3A4. But here’s the kicker—it’s nonlinear. Double the dose and you might triple the plasma concentration because the hepatic extraction becomes saturated. I’ve seen this catch residents off guard more times than I can count.

The extended-release formulations are designed to provide steady plasma levels over 24 hours, but they’re not interchangeable. The SR tablets and ER capsules have different release profiles, and switching between them requires dose adjustments.

Food interactions: Grapefruit juice inhibits CYP3A4 and can increase verapamil levels by 40-50%. I always tell patients to avoid grapefruit entirely while on Isoptin. Not just the juice—the whole fruit.

3. Mechanism of Action: How Isoptin Works

Let’s get into the weeds a bit. Verapamil blocks L-type calcium channels in cardiac myocytes and vascular smooth muscle cells. But unlike dihydropyridines that bind to the α1 subunit from the extracellular side, verapamil enters the cell and binds from the intracellular side. This explains its use-dependent block—the more frequently the channel opens, the more verapamil binds.

Cardiac effects:

  • SA node: Slows spontaneous depolarization → reduced heart rate
  • AV node: Prolongs effective refractory period → slows ventricular response in atrial fibrillation
  • Ventricular myocardium: Minimal direct effect at therapeutic doses (unlike class III antiarrhythmics)

Vascular effects:

  • Coronary arteries: Vasodilation → increased oxygen delivery
  • Peripheral arterioles: Vasodilation → reduced afterload → decreased myocardial oxygen demand

The net effect? For angina, it reduces oxygen demand while increasing supply. For hypertension, it drops peripheral resistance. For arrhythmias, it slows AV conduction.

One thing that’s often overlooked: verapamil also inhibits P-glycoprotein, which can increase levels of digoxin, dabigatran, and certain statins. More on that in the interactions section.

4. Indications for Use: What Is Isoptin Effective For?

4.1 Isoptin for Hypertension

First-line agent? Not anymore, but still widely used. The JNC 8 guidelines list CCBs as one of four preferred drug classes for non-black patients, but dihydropyridines (amlodipine) are usually chosen over verapamil due to fewer side effects. However, Isoptin shines in patients with concomitant atrial fibrillation or angina.

Clinical data: The ALLHAT trial (2002) included 33,357 patients and found that CCBs (amlodipine) were non-inferior to thiazides for major cardiovascular outcomes. While ALLHAT didn’t specifically use verapamil, the class effect is well-established.

4.2 Isoptin for Stable Angina Pectoris

This is where Isoptin really earns its keep. It’s effective for both effort-induced and vasospastic angina (Prinzmetal’s). The mechanism is dual: reduced afterload and coronary vasodilation.

Dosing tip: Start with 80 mg three times daily for immediate-release, then titrate up to 120 mg TID. For SR, 120-240 mg twice daily. I’ve found that many patients do well on 240 mg SR once daily, but the twice-daily regimen gives more consistent coverage.

4.3 Isoptin for Supraventricular Tachyarrhythmias

This is the acute indication that makes Isoptin indispensable in the ER. For PSVT (paroxysmal supraventricular tachycardia), IV verapamil 5-10 mg over 2 minutes can terminate the rhythm in 60-90% of cases.

For atrial fibrillation with rapid ventricular response, IV verapamil slows the rate within 3-5 minutes. But watch out—if the patient has pre-excitation (WPW syndrome), verapamil can accelerate conduction through the accessory pathway and cause ventricular fibrillation. This is a known risk and must be screened for.

4.4 Isoptin for Migraine Prophylaxis

Off-label, but evidence-based. The American Headache Society gives verapamil a Level B recommendation for migraine prevention. Typical dose is 120-240 mg daily of the extended-release formulation.

I had a patient, Maria, 52, with refractory migraines who failed propranolol, topiramate, and amitriptyline. We started Isoptin SR 180 mg daily, and within 6 weeks her migraine frequency dropped from 12 per month to 3. She still gets them, but they’re manageable. The constipation was a issue—we managed it with magnesium oxide 400 mg at bedtime.

5. Instructions for Use: Dosage and Course of Administration

IndicationFormulationStarting DoseTitrationMax Dose
HypertensionER/SR180 mg once dailyIncrease by 120 mg every 2 weeks480 mg/day
AnginaIR80 mg TIDIncrease to 120 mg TID480 mg/day
Arrhythmia (IV)IV5-10 mg over 2 minRepeat 10 mg after 30 min if needed20 mg total
Migraine prophylaxisSR120 mg once dailyIncrease to 240 mg after 2 weeks360 mg/day

Important administration notes:

  • SR/ER tablets should be swallowed whole—never crushed or chewed
  • Take with food to reduce GI irritation
  • Avoid abrupt discontinuation—taper over 2-3 weeks to prevent rebound hypertension or angina

Missed dose protocol: If less than 6 hours late, take it. If more than 6 hours late, skip and resume next scheduled dose. Doubling up can cause symptomatic bradycardia.

6. Contraindications and Drug Interactions

Absolute Contraindications

  • Severe left ventricular dysfunction (LVEF <35%)
  • Cardiogenic shock
  • Sick sinus syndrome (unless paced)
  • Second or third-degree AV block (unless paced)
  • Atrial fibrillation with WPW syndrome
  • Hypotension (SBP <90 mmHg)
  • Concomitant use of IV beta-blockers (risk of asystole)

Drug Interactions That Will Bite You

Digoxin: Verapamil increases digoxin levels by 50-70% through P-glycoprotein inhibition. I check digoxin levels after 5-7 days of starting verapamil and reduce the digoxin dose by 30-50%.

Statins: Simvastatin and lovastatin levels increase dramatically. The FDA warns against doses of simvastatin >10 mg with verapamil. Atorvastatin is safer but still needs monitoring.

Beta-blockers: Oral combination is acceptable with caution, but IV beta-blockers + IV verapamil is a recipe for asystole. Don’t do it.

Antiepileptics: Carbamazepine levels double. Phenytoin levels increase. Adjust accordingly.

Antifungals: Ketoconazole, itraconazole increase verapamil levels through CYP3A4 inhibition.

Grapefruit: Already mentioned, but worth repeating. Avoid entirely.

7. Clinical Studies and Evidence Base

Hypertension

The INVEST trial (2003) compared verapamil SR-based strategy to atenolol-based strategy in 22,576 hypertensive patients with CAD. Primary outcome (death, MI, stroke) was equivalent between groups. However, the verapamil group had less new-onset diabetes—a finding that supports its use in metabolic syndrome patients.

Angina

The APSIS trial (1996) compared verapamil to metoprolol in 809 patients with stable angina. Both drugs were equally effective for symptom control, but verapamil had fewer withdrawals due to adverse effects (fatigue, depression).

Arrhythmias

A meta-analysis by Lim et al. (1998) of 12 trials showed IV verapamil terminated PSVT in 86% of cases compared to 12% for placebo. Adenosine is now preferred due to shorter half-life, but verapamil remains useful when adenosine fails.

Heart Failure

This is where the data gets murky. The V-HeFT II trial suggested verapamil might worsen outcomes in heart failure with reduced EF. I avoid it in HFrEF. However, in HFpEF with atrial fibrillation, it’s reasonable.

8. Comparing Isoptin with Similar Products

DrugClassHeart RateAV ConductionVasodilationConstipation
VerapamilPhenylalkylamine↓↓↓↓↓↓+++
DiltiazemBenzothiazepine↓↓↓↓+
AmlodipineDihydropyridine↔↔↓↓↓-
NifedipineDihydropyridine↑ (reflex)↔↓↓↓-

Clinical pearl: If you need rate control and vasodilation, verapamil or diltiazem. If you need pure vasodilation without bradycardia, amlodipine. If you need to avoid constipation at all costs, don’t use verapamil.

9. Frequently Asked Questions about Isoptin

What is the typical starting dose for Isoptin in hypertension?

For extended-release, start at 180 mg once daily with food. Titrate to 240 mg after 2 weeks if needed. Max is 480 mg daily.

Can Isoptin be combined with an ACE inhibitor?

Absolutely. This is a common and effective combination for hypertension, especially in patients with diabetes or CKD. The ACE inhibitor blunts the reflex activation of the renin-angiotensin system.

How long does it take for Isoptin to work for angina?

Immediate-release formulations start working within 1-2 hours. For extended-release, steady-state is reached in 3-4 days. Most patients notice improvement within the first week.

Is Isoptin safe during pregnancy?

Verapamil is pregnancy category C. It’s been used for hypertension and arrhythmias in pregnancy, but data is limited. I’ve used it in the second and third trimesters when necessary, but I prefer labetalol or nifedipine as first-line.

What should I do if I miss a dose?

Take it if you remember within 6 hours. If more than 6 hours have passed, skip it. Never double up—this can cause dangerous bradycardia.

10. Conclusion: Validity of Isoptin Use in Clinical Practice

Look, Isoptin isn’t the newest drug on the block, and it’s not the sexiest. But it’s a proven workhorse with decades of clinical data backing its efficacy for hypertension, angina, and arrhythmias. The key is knowing when to use it and when to steer clear.

When I reach for Isoptin:

  • Hypertensive patient with atrial fibrillation needing rate control
  • Stable angina with contraindication to beta-blockers (asthma, COPD)
  • PSVT that fails adenosine
  • Migraine prophylaxis after first-line agents fail

When I avoid it:

  • Heart failure with reduced EF
  • WPW syndrome with atrial fibrillation
  • Concomitant IV beta-blocker use
  • Patients with severe constipation (they’ll hate me)

I remember a case from my second year of cardiology fellowship. A 68-year-old man, Mr. Henderson, came in with rapid atrial fibrillation at 160 bpm, BP 110/70. He had COPD and couldn’t take beta-blockers. We gave him IV verapamil 5 mg over 2 minutes. Within 4 minutes, his rate dropped to 90, his BP held at 105/68, and he was breathing easier. He looked at me and said, “Doc, that’s the best I’ve felt in weeks.”

That’s the thing about Isoptin—it’s not flashy, but it works. And when you’ve been in practice long enough, you learn to appreciate the drugs that just do their job without causing too much trouble.

For patients: Take it consistently, watch for constipation (magnesium, psyllium, or docusate can help), avoid grapefruit, and don’t stop abruptly. Most people tolerate it well for years.

For clinicians: Remember the nonlinear pharmacokinetics, the CYP3A4 interactions, and the contraindications. Used wisely, Isoptin is a valuable tool in your cardiovascular arsenal.

Last updated: November 2024. This monograph reflects current evidence and clinical practice guidelines. Individual patient factors should always guide treatment decisions.